Don’t miss the latest developments in business and finance.

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Image
Last Updated : Aug 30 2024 | 12:31 PM IST
Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and pathological services business of Vimta Labs.

Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Aug 30 2024 | 12:17 PM IST

Next Story